TNXP - Tonix Pharmaceuticals GAAP EPS of -$1.22 beats by $0.23
- Tonix Pharmaceuticals press release ( NASDAQ: TNXP ): Q2 GAAP EPS of -$1.22 beats by $0.23 .
- As of June 30, 2022, Tonix had $145.5 million of cash and cash equivalents, compared to $178.7 million as of December 31, 2021.
- Shares +0.63% PM.
For further details see:
Tonix Pharmaceuticals GAAP EPS of -$1.22 beats by $0.23